1. Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy

   • Robert S. Rosenson

   Leading Article 20 August 2012 Pages: 411 - 420

   

2. Oral Glycoprotein IIb/IIIa Inhibitors

   • Derek P. Chew
   • Deepak L. Bhatt
   • Eric J. Topol

   Leading Article 20 August 2012 Pages: 421 - 428

   

3. Drugs for the Prevention and Treatment of Thrombosis in Patients with Heparin-Induced Thrombocytopenia

   • Norbert Lubenow
   • Andreas Greinacher

   Therapy in Practice 20 August 2012 Pages: 429 - 443

   

4. Contemporary Management of Children with Atrial Septal Defects

   • Rolf G. Bennhagen
   • Peter McLaughlin
   • Lee N. Benson

   Review Article 20 August 2012 Pages: 445 - 453

   

5. Hypertriglyceridemia

   • Iris J. A. M. Jonkers
   • August H. M. Smelt
   • Arnoud van der Laarse

   Review Article 20 August 2012 Pages: 455 - 466

   

6. Clopidogrel

   • Stephanie E. Easthope
   • Blair Jarvis

   Adis New Indication Profile 20 August 2012 Pages: 467 - 474

   

7. Clopidogrel

   • David H. Fitchett

   Guest Commentaries 20 August 2012 Pages: 475 - 475

8. Clopidogrel

   • William E. Boden

   Guest Commentaries 20 August 2012 Pages: 475 - 475

9. Clopidogrel

   • Robert M. Califf

   Guest Commentaries 20 August 2012 Pages: 476 - 476

10. Enoxaparin

    • Gregory T. Warner
    • Caroline M. Perry

    Adis New Indication Profile 20 August 2012 Pages: 477 - 481

    

11. Enoxaparin

    • Greg Elliott

    Guest Commentaries 20 August 2012 Pages: 483 - 483

12. Enoxaparin

    • James J. Ferguson

    Guest Commentaries 20 August 2012 Pages: 483 - 483

13. From the World Literature

    OriginalPaper 20 August 2012 Pages: 485 - 493